Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05321745

Fecal Microbiota Transplantation in Pediatric Crohn's Disease

Repeated and Periodic Fecal Microbiota Transplantation in Children With Active and Refractory Crohn's Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Biao Zou · Academic / Other
Sex
All
Age
2 Years – 16 Years
Healthy volunteers
Not accepted

Summary

This study will test the safety and effectiveness of fecal microbiota transplantation (FMT) plus partial enteral nutrition (PEN) in refractory pediatric Crohn's disease (CD) who have failed conventional treatment

Detailed description

Recent studies have suggested that gut imbalance and deregulation of immunological responses plays a pivotal role in the disease development of Crohn's disease (CD), and that FMT could be a useful treatment. Our study is aims to repeated and multiple FMTs plus PEN in the treatment of refractory pediatric CD. In the induction stage of CD, standard therapy remained unchanged, FMT and PEN were added, and FMT was given 1-2 courses, 3-6 times per course. In the maintaining stage, FMT was performed every 3 months, with the same 3-6 times of FMT treatment for each course, and the withdrawal of conventional drug therapy was gradually reduced. Refractory CD was defined as refractory to standard therapy (e.g., steroids, immunomodulators, cyclosporine, tacrolimus, or anti-TNF agents).

Conditions

Interventions

TypeNameDescription
OTHERStandardized FMTFecal microbiota transplantation of fresh bacteria from healthy donor to the whole colon

Timeline

Start date
2022-03-22
Primary completion
2026-05-31
Completion
2026-05-31
First posted
2022-04-11
Last updated
2024-11-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05321745. Inclusion in this directory is not an endorsement.